Core Viewpoint - Lin Qingxuan Cosmetics Group officially listed on the Hong Kong Stock Exchange on December 30, 2025, with a strong IPO performance, raising approximately HKD 997 million for R&D, channel expansion, and brand upgrades [2][3] Group 1: Company Overview - Lin Qingxuan was founded in 2003 and has established a unique position in the Chinese skincare market with its "oil-based skincare" philosophy [2] - The company's core product, Camellia Oil Essence, has been the top-selling facial oil in China since its launch in 2014, with cumulative sales exceeding 50 million bottles [2][3] Group 2: Financial Performance - In the first half of 2025, Lin Qingxuan achieved revenue of CNY 1.052 billion, a year-on-year increase of 98% [2] - Gross profit reached CNY 866 million, reflecting a 99.5% year-on-year growth, while net profit surged to CNY 182 million, up 110.16% year-on-year [2] Group 3: Market Position and Innovation - According to Zhaoshang Consulting, Lin Qingxuan ranks first among high-end domestic skincare brands in China by retail sales in 2024, being the only domestic brand in the top 15 high-end skincare brands [3] - The company has increased its R&D investment, resulting in over 600 formula achievements and 87 patents, including 46 invention patents [3] Group 4: Strategic Initiatives - The release of the "Three-Year Action Plan for the Improvement of Quality Management System in Cosmetic Enterprises (2026-2028)" aligns with Lin Qingxuan's strategic development of high-altitude Camellia flower bases in Zhejiang and Jiangxi, creating a competitive barrier [3] - The founder, Sun Laichun, indicated plans to enhance R&D in skin science, botany, and cutting-edge skincare technologies, while also optimizing key products for better consumer experience and shareholder value [3]
林清轩成功登陆港股